BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 15186618)

  • 41. [Frequency of thyroid gland carcinoma in hyperthyroidism].
    Krause U; Olbricht T; Metz K; Rudy T; Reiners C
    Dtsch Med Wochenschr; 1991 Feb; 116(6):201-6. PubMed ID: 1993431
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interferon-alpha-induced hyperthyroidism: a three-stage evolution from silent thyroiditis towards Graves' disease.
    Bohbot NL; Young J; Orgiazzi J; Buffet C; François M; Bernard-Chabert B; Lukas-Croisier C; Delemer B
    Eur J Endocrinol; 2006 Mar; 154(3):367-72. PubMed ID: 16498048
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Thyroid cancers masked by hyperthyroidism. 12 cases].
    Blondeau PH; Legros A; René L
    J Chir (Paris); 1976 Mar; 111(3):271-88. PubMed ID: 783175
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Benign thyroid disease: what is the role of nuclear medicine?
    Sarkar SD
    Semin Nucl Med; 2006 Jul; 36(3):185-93. PubMed ID: 16762609
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Hyperthyroidism and cancer of the thyroid].
    Nicolosi A; Addis E; Calò PG; Tarquini A
    Minerva Chir; 1994 Jun; 49(6):491-5. PubMed ID: 7970050
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Usefulness of [99mTC]MIBI and [18F]fluorodeoxyglucose for imaging recurrent medullary thyroid cancer and hyperparathyroidism in MEN 2a syndrome.
    Roelants V; Michel L; Lonneux M; Lacrosse M; Delgrange E; Donckier JE
    Acta Clin Belg; 2001; 56(6):373-7. PubMed ID: 11881324
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders.
    Elisei R; Bottici V; Luchetti F; Di Coscio G; Romei C; Grasso L; Miccoli P; Iacconi P; Basolo F; Pinchera A; Pacini F
    J Clin Endocrinol Metab; 2004 Jan; 89(1):163-8. PubMed ID: 14715844
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mixed medullary-follicular and medullary-papillary carcinoma of the thyroid: one or two entities?
    Michal M; Curík R; Macák J; Ludvíková M; Dĕdic K
    Zentralbl Pathol; 1993 Nov; 139(4-5):333-5. PubMed ID: 8130165
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Thyroid hemiagenesis associated with medullary or papillary carcinoma: report of cases.
    Wang J; Gao L; Song C
    Head Neck; 2014 Nov; 36(11):E106-11. PubMed ID: 24115043
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The variable pathologic presentations of medullary and micro-medullary thyroid carcinoma: an institutional experience.
    Samulski TD; Livolsi VA; Montone K; Baloch Z
    Pathol Res Pract; 2014 Mar; 210(3):182-5. PubMed ID: 24440099
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MIBG for diagnosis and therapy of medullary thyroid carcinoma: is there still a role?
    Castellani MR; Seregni E; Maccauro M; Chiesa C; Aliberti G; Orunesu E; Bombardieri E
    Q J Nucl Med Mol Imaging; 2008 Dec; 52(4):430-40. PubMed ID: 19088696
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular pathology of hereditary and sporadic medullary thyroid carcinomas.
    Chernock RD; Hagemann IS
    Am J Clin Pathol; 2015 Jun; 143(6):768-77. PubMed ID: 25972318
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Thyroid cancer prevalence after radioiodine treatment of hyperthyroidism.
    Angusti T; Codegone A; Pellerito R; Favero A
    J Nucl Med; 2000 Jun; 41(6):1006-9. PubMed ID: 10855625
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mortality from thyroid cancer in patients with hyperthyroidism: the Theagenion Cancer Hospital experience.
    Pazaitou-Panayiotou K; Perros P; Boudina M; Siardos G; Drimonitis A; Patakiouta F; Vainas I
    Eur J Endocrinol; 2008 Dec; 159(6):799-803. PubMed ID: 18819945
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Mixed medullary-papillary thyroid carcinoma: report of a case].
    Gao ZB; Wang ZP; Zhao Y; Yu XR
    Zhonghua Bing Li Xue Za Zhi; 2008 Oct; 37(10):716-7. PubMed ID: 19094497
    [No Abstract]   [Full Text] [Related]  

  • 56. The prevalence of occult medullary thyroid carcinoma at autopsy.
    Valle LA; Kloos RT
    J Clin Endocrinol Metab; 2011 Jan; 96(1):E109-13. PubMed ID: 20943788
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Disseminated medullary thyroid carcinoma despite early thyroid surgery in the multiple endocrine neoplasia-2A syndrome.
    van Santen HM; Aronson DC; van Trotsenburg AS; ten Kate FJ; van de Wetering MD; Wiersinga WM; de Vijlder JJ; Vulsma T
    Thyroid; 2005 May; 15(5):485-8. PubMed ID: 15929671
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nodular Graves' disease with medullary thyroid cancer.
    Khan SH; Rather TA; Makhdoomi R; Malik D
    Indian J Nucl Med; 2015; 30(4):341-4. PubMed ID: 26430321
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Incidental medullary thyroid carcinoma in a case of Graves' disease.
    Nakamura S; Saio Y; Ishimori M; Shima H
    Intern Med; 2002 Apr; 41(4):323-4. PubMed ID: 11993796
    [No Abstract]   [Full Text] [Related]  

  • 60. Breast metastasis from medullary carcinoma of thyroid: A case report with literature view.
    Mukhtar R; Hussain M; Mukhtar MA; Ali SM
    J Pak Med Assoc; 2020 Nov; 70(11):2051-2053. PubMed ID: 33341859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.